Anonymous
Guest
Anonymous
Guest
They steer the ship.
They coach the troops.
They provide wisdom and astute observations.
We need more of them, maybe one per rep.
They provide daily insights with conference calls.
Might they really be giant squids? I get that most are just trying to salvage their jobs however, there are the few that believe the crap they spew. The complete douche bags that utter nonsense in a futile attempt to make themselves important. What other industry employs a band of managers at 150K annually to babysit its tenured sales force in a ratio of 7:1.
If merck decided to reduce the CTL head by 50% they would save millions and it would have zero impact on sales. Most all systems are automated today and the sales force has a average tenure of over 14 years.
Let's turn our attention next to Merck's marketing department. They wisdom they have displayed over the last few years is mind boggling. The launch of Juvisync, Liptruzet, Dulera blunders and using regular metformin instead of XR to launch it------just to name a few. I guess Merck considers these highly compensated folks real talent that they must hang on to.
They coach the troops.
They provide wisdom and astute observations.
We need more of them, maybe one per rep.
They provide daily insights with conference calls.
Might they really be giant squids? I get that most are just trying to salvage their jobs however, there are the few that believe the crap they spew. The complete douche bags that utter nonsense in a futile attempt to make themselves important. What other industry employs a band of managers at 150K annually to babysit its tenured sales force in a ratio of 7:1.
If merck decided to reduce the CTL head by 50% they would save millions and it would have zero impact on sales. Most all systems are automated today and the sales force has a average tenure of over 14 years.
Let's turn our attention next to Merck's marketing department. They wisdom they have displayed over the last few years is mind boggling. The launch of Juvisync, Liptruzet, Dulera blunders and using regular metformin instead of XR to launch it------just to name a few. I guess Merck considers these highly compensated folks real talent that they must hang on to.